The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global organ preservation market was valued at US$ 163.5 Million in 2021.
We expect the global organ preservation market to exhibit a CAGR of 6.8% during 2022-2027.
The high prevalence of several chronic diseases, continuous advancements in the organ preservation infrastructures, and the rising number of volunteers to donate their organs for transplantation, are primarily driving the global organ preservation market.
The sudden outbreak of the COVID-19 pandemic had led to the delay in elective organ transplantation procedures to mitigate the risk of the coronavirus infection upon hospital visits and interaction with healthcare professionals, thereby negatively impacting the demand for organ preservation.
Based on the preservation solution, the global organ preservation market can be segmented into UW solution, custodiol HTK, perfadex, and others. Currently, UW solution holds the majority of the total market share.
Based on the organ donation type, the global organ preservation market has been divided into living organ donation and deceased organ donation, where deceased organ donation currently exhibits a clear dominance in the market.
Based on the technique, the global organ preservation market can be categorized into static cold storage technique, hypothermic machine perfusion, normothermic machine perfusion, and others. Currently, static cold storage technique accounts for the majority of the global market share.
Based on the organ type, the global organ preservation market has been segregated into kidney, liver, lung, heart, and others. Among these, kidney currently holds the largest market share.
Based on the end-user, the global organ preservation market can be bifurcated into hospitals and clinics, organ banks, and others. Currently, organ banks exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global organ preservation market include 21st Century Medicine, Biolife Solutions, Bridge to Life Ltd., Bristol-Myers Squibb, Dr. Franz Köhler Chemie GmbH, Essential Pharmaceuticals., Lifeline Scientific, OrganOx, Paragonix Technologies, TransMedics, Waters Medical Systems, Xvivo Perfusion, etc.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at